These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21673540)

  • 1. Intravenous fluid therapy successfully prevents renal injury by gemcitabine in patients with pancreatic cancer.
    Ko SB; Azuma S; Kamimura K; Goto H; Anzai N; Yamamoto A; Ishiguro H; Mizuno N
    Pancreas; 2011 Jul; 40(5):784-6. PubMed ID: 21673540
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of progressive hypertension preceding gemcitabine-associated thrombotic microangiopathy complicated by acute kidney injury and stroke.
    Phelan PJ; Liew A; Magee C
    Ren Fail; 2009; 31(8):743-4. PubMed ID: 19814643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the Tolerability of Gemcitabine and Cisplatin Combination Chemotherapy with a Small Quantity of Replacement Fluid for Biliary Tract Cancer].
    Ichimura T; Nawata S; Ichikura D; Murakami K; Usuda M; Kawashima W; Minemura A; Sasaki T
    Yakugaku Zasshi; 2020; 140(7):929-936. PubMed ID: 32612058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II/III study comparing intravenous ZD9331 with gemcitabine in patients with pancreatic cancer.
    Smith D; Gallagher N
    Eur J Cancer; 2003 Jul; 39(10):1377-83. PubMed ID: 12826040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute tubulointerstitial nephritis associated with long-term gemcitabine therapy.
    Yamamoto A; Naruse S; Ito M; Ishiguro H; Ko SB; Yoshikawa T; Kondo T; Goto H
    Pancreas; 2007 Apr; 34(3):378-9. PubMed ID: 17414063
    [No Abstract]   [Full Text] [Related]  

  • 6. Gemcitabine and platinum combinations in pancreatic cancer.
    Philip PA
    Cancer; 2002 Aug; 95(4 Suppl):908-11. PubMed ID: 12209670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy.
    Kanai M; Matsumoto S; Nishimura T; Matsumura Y; Hatano E; Mori A; Masui T; Kawaguchi Y; Nakamura E; Tada S; Kitano T; Ishiguro H; Yanagihara K; Chiba T
    Ann Oncol; 2010 Jan; 21(1):189-90. PubMed ID: 19889615
    [No Abstract]   [Full Text] [Related]  

  • 8. [42-year-old patient with renal insufficience, anemia and thrombocytopenia during chemotherapy].
    Schoel G; Schrader J; Bäsecke J
    Dtsch Med Wochenschr; 2020 Apr; 145(8):523-524. PubMed ID: 32294777
    [No Abstract]   [Full Text] [Related]  

  • 9. Gemcitabine in the treatment of metastatic pancreatic cancer.
    Hilbig A; Oettle H
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):511-23. PubMed ID: 18402518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nab-paclitaxel and gemcitabine for the treatment of patients with metastatic pancreatic cancer.
    Borazanci E; Von Hoff DD
    Expert Rev Gastroenterol Hepatol; 2014 Sep; 8(7):739-47. PubMed ID: 24882381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.
    Neoptolemos JP; Stocken DD; Bassi C; Ghaneh P; Cunningham D; Goldstein D; Padbury R; Moore MJ; Gallinger S; Mariette C; Wente MN; Izbicki JR; Friess H; Lerch MM; Dervenis C; Oláh A; Butturini G; Doi R; Lind PA; Smith D; Valle JW; Palmer DH; Buckels JA; Thompson J; McKay CJ; Rawcliffe CL; Büchler MW;
    JAMA; 2010 Sep; 304(10):1073-81. PubMed ID: 20823433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Livedo reticularis as an initial clinical manifestation of gemcitabine-induced hemolytic uremic syndrome.
    Zemtsov A; Omueti-Ayoade K; Zemtsov R; Yang M
    J Dermatol; 2012 May; 39(5):487-9. PubMed ID: 21906135
    [No Abstract]   [Full Text] [Related]  

  • 13. Palliative first-line treatment with weekly high-dose 5-fluorouracil as 24h-infusion and gemcitabine in metastatic pancreatic cancer (UICC IV).
    Roehrig S; Wein A; Albrecht H; Konturek PC; Reulbach U; Männlein G; Wolff K; Ostermeier N; Hohenberger W; Hahn EG; Boxberger F
    Med Sci Monit; 2010 Mar; 16(3):CR124-131. PubMed ID: 20190682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemcitabine-induced hemolytic-uremic syndrome treated with eculizumab or plasmapheresis: two case reports
.
    López Rubio ME; Rodado Martínez R; Illescas ML; Mateo Bosch E; Martinez Díaz M; de la Vara Inesta L; Cabezuelo B; Morales Albuja ME; Lucas Guillén E; Jimeno García L
    Clin Nephrol; 2017 Feb; 87 (2017)(2):100-106. PubMed ID: 27879189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herceptin and gemcitabine for metastatic pancreatic cancers that overexpress HER-2/neu.
    Safran H; Iannitti D; Ramanathan R; Schwartz JD; Steinhoff M; Nauman C; Hesketh P; Rathore R; Wolff R; Tantravahi U; Hughes TM; Maia C; Pasquariello T; Goldstein L; King T; Tsai JY; Kennedy T
    Cancer Invest; 2004; 22(5):706-12. PubMed ID: 15581051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine-induced hemolytic uremic syndrome in pancreatic cancer: a case report and review of the literature.
    Lee HW; Chung MJ; Kang H; Choi H; Choi YJ; Lee KJ; Lee SW; Han SH; Kim JS; Song SY
    Gut Liver; 2014 Jan; 8(1):109-12. PubMed ID: 24516709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I study of combination of intravenous gemcitabine, oxaliplatin, and 5-FU with daily oral thalidomide (GOFT) in metastatic/locally advanced pancreatic carcinoma patients.
    Shan YS; Lin PW
    Hepatogastroenterology; 2007; 54(79):2141-5. PubMed ID: 18251177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Updated Meta-analysis and System Review:is Gemcitabine+Fluoropyrimidine in Combination a Better Therapy Versus Gemcitabine Alone for Advanced and Unresectable Pancreatic Cancer?
    Tu C; Zheng F; Wang JY; Li YY; Qian KQ
    Asian Pac J Cancer Prev; 2015; 16(14):5681-6. PubMed ID: 26320435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fixed-dose rate gemcitabine in elderly patients with advanced pancreatic cancer: an observational study.
    Locher C; Fabre-Guillevin E; Brunetti F; Auroux J; Delchier JC; Piedbois P; Zelek L
    Crit Rev Oncol Hematol; 2008 Nov; 68(2):178-82. PubMed ID: 18672379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of gemcitabine in a patient with end-stage renal disease: effective clearance of its main metabolite by standard hemodialysis treatment.
    Kiani A; Köhne CH; Franz T; Passauer J; Haufe T; Gross P; Ehninger G; Schleyer E
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):266-70. PubMed ID: 12655447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.